Lea is a member of Newton’s equity research team. In her current role, she is responsible for covering life science tools equities.
- Joined industry
- 2021
- Joined the Group
- 2021
Topics of expertise
Lea joined Newton in September 2021, following the integration of Mellon Investments Corporation’s equity and multi-asset capabilities into the Newton Investment Management Group. Prior to her role as an analyst, Lea was a member of the firm’s research associate team.
Lea has a BS in Operations Research from Cornell University.
